Open AccessA randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke
Author(s) -
Pawan Kumar Sharma,
Mumun Sinha,
Rakesh Shukla,
Richa Garg,
Rajesh Verma,
Maneesh Singh
Publication year - 2011
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.82794
Subject(s) - edaravone , medicine , free radical scavenger , modified rankin scale , placebo , barthel index , placebo group , anesthesia , randomized controlled trial , clinical trial , physical therapy , ischemic stroke , activities of daily living , ischemia , oxidative stress , alternative medicine , pathology
Edaravone has potent antioxidant and free radical scavenger properties. Few Japanese studies had demonstrated its neuroprotective role in acute ischemic stroke (AIS). This study aims to evaluate the efficacy of edaravone in terms of functional outcome in a group of Indian patients of AIS.